| General Information of Drug Metabolite (DM) (ID: DM005009) |
| DM Name |
ETC-1002-CoA
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Very long-chain acyl-CoA synthetase (SLC27A2)
|
DMEN256
|
| Unclear - Unclear |
Bempedoic acid
|
[1] , [2] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 2B7 (UGT2B7)
|
DME0040
|
| Unclear - Unclear |
Bempedoic acid
|
[3] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Bempedoic acid |
DR5353
|
Approved |
Hypertriglyceridaemia |
|
|
| References |
| 1 |
Bempedoic Acid (ETC-1002): A Current Review
|
| 2 |
The Disposition and Metabolism of Bempedoic Acid, a Potent Inhibitor of ATP Citrate Lyase, in Healthy Human Subjects
|
| 3 |
DrugBank(Pharmacology-Metabolism):Bempedoic acid
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
